Synektik

Synektik Days Payable Outstanding

The Days Payable Outstanding (DPO) of Synektik (SNT.WA) as of Nov 3, 2026 is 115.56. In the previous year, Days Payable Outstanding (DPO) was 76.33 — a change of 51.39% (higher).

Days Payable Outstanding

115.56

YoY

51.39%

Last updated:

Days Payable Outstanding (DPO) of Synektik is 2025 115.56 . Days Payable Outstanding (DPO) of Synektik was 2024 76.33 . It decreases by 51.39% higher compared to the previous year.

The Synektik Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2018
105.08 PLN
Jan 1, 2019
85.42 PLN
Jan 1, 2020
106.23 PLN
Jan 1, 2021
164.92 PLN
Jan 1, 2022
220.79 PLN
Jan 1, 2023
105.22 PLN
Jan 1, 2024
76.33 PLN
Jan 1, 2025
115.56 PLN
The Synektik Days Payable Outstanding history
YEARDays Payable OutstandingYoY
115.56+51.39%
76.33-27.45%
105.22-52.34%
220.79+33.87%
164.92+55.25%
106.23+24.36%
85.42-18.71%
105.08-58.23%
251.56+75.07%
143.69+3.57%
138.74-13.89%
161.13—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

Days Payable Outstanding (DPO) of Synektik is 115.56 in 2025.

Days Payable Outstanding (DPO) of Synektik changed from 76.33 to 115.56, representing a 51.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Synektik since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Synektik with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Synektik

All Key Metrics — Synektik